IQVIA Holdings (LTS:0JDM) Cyclically Adjusted Revenue per Share: $78.22 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0JDM IQVIA Holdings Inc LTS:0JDM
86 GF Score
Price $207.99
GF Value $250.08
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Cyclically Adjusted Revenue per Share?

IQVIA Holdings LTS:0JDM -1.21% 86 Cyclically Adjusted Revenue per Share is $78.22 as of Mar. 2026. GuruFocus rates LTS:0JDM with a GF Score™ of 86/100 and a GF Value™ of $250.08 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

IQVIA Holdings's adjusted revenue per share for the three months ended in Mar. 2026 was $24.446. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $78.22 for the trailing ten years ended in Mar. 2026.

During the past 12 months, IQVIA Holdings's average Cyclically Adjusted Revenue Growth Rate was 7.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of IQVIA Holdings was 8.90% per year. The lowest was 7.50% per year. And the median was 8.20% per year.

As of today (2026-07-15), IQVIA Holdings's current stock price is $207.99. IQVIA Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $78.22. IQVIA Holdings's Cyclically Adjusted PS Ratio of today is 2.66.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IQVIA Holdings was 5.17. The lowest was 1.88. And the median was 3.22.


IQVIA Holdings  (LTS:0JDM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IQVIA Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=207.99/78.22
=2.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IQVIA Holdings was 5.17. The lowest was 1.88. And the median was 3.22.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


IQVIA Holdings Cyclically Adjusted Revenue per Share Related Terms


IQVIA Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings Cyclically Adjusted Revenue per Share Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.47 60.72 66.09 71.19 76.63

IQVIA Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.74 74.18 73.40 76.63 78.22

LTS:0JDM vs WAT, ILMN, NTRA: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, IQVIA Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Cyclically Adjusted PS Ratio falls into.


LTS:0JDM
86GF Score
IQVIA Holdings Inc LTS:0JDM
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IQVIA Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=24.446/330.2130*330.2130
=24.446

Current CPI (Mar. 2026) = 330.2130.

IQVIA Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 12.782 241.018 17.512
201609 12.351 241.428 16.893
201612 9.664 241.432 13.218
201703 10.047 243.801 13.608
201706 10.594 244.955 14.281
201709 11.260 246.819 15.064
201712 11.769 246.524 15.764
201803 12.090 249.554 15.998
201806 12.230 251.989 16.027
201809 12.544 252.439 16.409
201812 13.176 251.233 17.318
201903 13.307 254.202 17.286
201906 13.659 256.143 17.609
201909 13.915 256.759 17.896
201912 14.703 256.974 18.893
202003 14.073 258.115 18.004
202006 13.206 257.797 16.916
202009 14.295 260.280 18.136
202012 16.887 260.474 21.408
202103 17.491 264.877 21.805
202106 17.640 271.696 21.439
202109 17.363 274.310 20.901
202112 18.646 278.802 22.084
202203 18.449 287.504 21.190
202206 18.530 296.311 20.650
202209 18.807 296.808 20.924
202212 19.836 296.797 22.069
202303 19.364 301.836 21.184
202306 19.968 305.109 21.611
202309 20.140 307.789 21.607
202312 20.965 306.746 22.569
202403 20.277 312.332 21.438
202406 20.695 314.175 21.751
202409 21.151 315.301 22.151
202412 21.904 315.605 22.918
202503 21.584 319.799 22.287
202506 23.193 322.561 23.743
202509 23.879 324.800 24.277
202512 25.416 324.054 25.899
202603 24.446 330.213 24.446

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $78.22 mean?
IQVIA Holdings (LTS:0JDM) has a Cyclically Adjusted Revenue per Share of $78.22 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IQVIA Holdings and its competitors.
Is IQVIA Holdings' Cyclically Adjusted Revenue per Share too high?
IQVIA Holdings' current Cyclically Adjusted Revenue per Share is $78.22. Overall, IQVIA Holdings has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Cyclically Adjusted Revenue per Share compare to WAT and ILMN?
IQVIA Holdings' Cyclically Adjusted Revenue per Share of $78.22 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current Cyclically Adjusted Revenue per Share is $78.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (LTS:0JDM) is currently considered Modestly Undervalued. The stock's GF Value™ is $250.08, compared to a current price of $207.99 — trading 16.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $78.22. IQVIA Holdings' overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For IQVIA Holdings (LTS:0JDM), the current Cyclically Adjusted Revenue per Share is $78.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (LTS:0JDM) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of $207.99 is trading 16.8% below its estimated GF Value™ of $250.08. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for LTS:0JDM:

  • Cyclically Adjusted Revenue per Share: $78.22
  • GF Value™: $250.08 vs. price of $207.99 (16.8% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the LTS:0JDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
86GF Score

Get the complete analysis for LTS:0JDM

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$207.99
Price
$250.08
GF Value